Alex

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found…

CORRECTING and REPLACING Aurora, PTT Station, and Royal Umbrella are among the Winners of the 2023 – 2024 World Branding Awards

LONDON--(BUSINESS WIRE)--#worldbranding--Fourth paragraph, first sentence of release dated December 8, 2023, should read: Winners from…

MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023

HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU” or the “Company”), a KOL-driven online fashion and…

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an…

U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)

HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced…

Rocket Lab Reaches New Annual Launch Record with 10th Electron Mission This Year

The mission successfully deployed a satellite for Japan-based Earth imaging company Institute for Q-shu Pioneers…

 Elliptic Labs Launches with Vivo S18 and S18 Pro Smartphones

OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…

LTIMindtree Opens New Delivery Center in Mexico City

MEXICO CITY & MUMBAI, India--(BUSINESS WIRE)--$LTIM #DeliveryCenter--LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting…

The KAYTUS V2 Series Servers Support 5th Gen Intel® Xeon® Processors, Maximizing Performance at Server Unit Energy Consumption

With unrivaled innovative system design capabilities, the V2 series servers achieve sustainable development in cloud…